Wed, December 2, 2015
Tue, December 1, 2015
Mon, November 30, 2015
Wed, November 25, 2015
Tue, November 24, 2015
Mon, November 23, 2015
Sun, November 22, 2015
Fri, November 20, 2015
Thu, November 19, 2015
Wed, November 18, 2015
Tue, November 17, 2015
Mon, November 16, 2015
Fri, November 13, 2015
Thu, November 12, 2015
Wed, November 11, 2015
Tue, November 10, 2015
Mon, November 9, 2015
Fri, November 6, 2015
Thu, November 5, 2015
Wed, November 4, 2015
Tue, November 3, 2015
Mon, November 2, 2015
Fri, October 30, 2015
Thu, October 29, 2015
Wed, October 28, 2015
Tue, October 27, 2015
Mon, October 26, 2015
Fri, October 23, 2015
Thu, October 22, 2015
Wed, October 21, 2015
Tue, October 20, 2015
Mon, October 19, 2015
Fri, October 16, 2015
Thu, October 15, 2015
Wed, October 14, 2015
Tue, October 13, 2015
Mon, October 12, 2015
Sat, October 10, 2015
Fri, October 9, 2015

Andrew Fein Upgraded (VRTX) to Strong Buy and Increased Target to $155 on, Oct 30th, 2015


//stocks-investing.news-articles.net/content/201 .. nd-increased-target-to-155-on-oct-30th-2015.html
Published in Stocks and Investing on Friday, October 25th 2024 at 10:27 GMT by WOPRAI   Print publication without navigation


Andrew Fein of HC Wainwright & Co., Upgraded "Vertex Pharmaceuticals Incorporated" (VRTX) to Strong Buy and Increased Target from $85 to $155 on, Oct 30th, 2015.

Andrew has made no other calls on VRTX in the last 4 months.



There are 5 other peers that have a rating on VRTX. Out of the 5 peers that are also analyzing VRTX, 2 agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Biren Amin of "Jefferies" Initiated at Hold and Held Target at $130 on, Wednesday, September 9th, 2015
  • Ying Huang of "B of A Securities" Maintained at Hold with Increased Target to $133 on, Monday, July 6th, 2015


These are the ratings of the 3 analyists that currently disagree with Andrew


  • Matthew Harrison of "Morgan Stanley" Upgraded from Hold to Buy and Increased Target to $148 on, Friday, October 2nd, 2015
  • Jasper Hellweg of "Argus Research" Upgraded from Hold to Strong Buy on, Monday, September 28th, 2015
  • Liisa Bayko of "JMP Securities" Maintained at Buy with Increased Target to $148 on, Thursday, July 30th, 2015

Publication Contributing Sources